Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of aTyr Pharma Inc (NASDAQ: LIFE) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of aTyr Pharma Inc (NASDAQ: LIFE) concerning whether a series of statements by aTyr Pharma Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On May 7, 2015, aTyr Pharma stock traded as high as $15.01, the Company sold 5.36 million shares of stock in its initial public stock offering raising $75 million in new capital.  Since the initial public stock offering, aTyr Pharma's stock have fallen from $28.29 in June 2015 to trade at $3.15 in early morning trading on April 7, 2016.

Based in San Diego, CA, and founded in 2005 aTyr Pharma Inc is engaged in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases.

If you purchased shares of aTyr Pharma Inc (NASDAQ: LIFE), you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185